Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0204-2024Class II

Coapt ControlSeal Electrode, cutaneous EMG Electrode

Coapt LLC / initiated 2023-10-02 / Open, Classified / root cause: manufacturing process

Coapt LLC began a recall of Coapt ControlSeal Electrode, cutaneous EMG Electrode on . FDA classified it as Class II and gives the reason as "Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0204-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Coapt LLC
Product
Coapt ControlSeal Electrode, cutaneous EMG Electrode
Product code
GXY Electrode, Cutaneous
Reason for recall
Patient may experience minor burn or blistering if device is exposed to direct sunlight and/or warm temperatures for over 12 hours or battery is damaged.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
Coapt, LLC issued a Medical Device Correction notice to its consignees on 10/02/2023 via email. The notice explained the problem, risk, and urged users to take precautions as described in the most recent handbook: https://coaptengineering.com/clinicians. The handbook is under "Downloadable product handbooks."
Quantity in commerce
109 devices
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Canada, and Sweden.
Product codes and lots
UDI/DI: +B618P1/$+202210P1603, All serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0204-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0204-2024Class IIOngoingVoluntary: Firm initiated